Predicting pulmonary adenocarcinoma outcome based on a cytology grading system

Cancer Cytopathology

Volumn 120, Issue 1, 2012, Pages 35-43

  Sige, Carlie S ^a   Rudomina, Dorota E ^a   Sima, Camelia S ^a   Rekhtman, Natasha ^a   Travis, William D ^a   Geisinger, Kim R ^b   Moreira, Andre L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cytology grading; Lung adenocarcinoma; Prognosis; Survival

Indexed keywords

ADULT; AGED; CANCER GRADING; CANCER PROGNOSIS; CHROMATIN STRUCTURE; CYTOARCHITECTURE; CYTOLOGY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR SIZE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; ADENOCARCINOMA; ARTICLE; CYTODIAGNOSIS; LUNG TUMOR; METHODOLOGY; MIDDLE AGED; MORTALITY; NEEDLE BIOPSY; PATHOLOGY; PREDICTIVE VALUE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CYTODIAGNOSIS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; PREDICTIVE VALUE OF TESTS;

EID: 84859791404     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20185     Document Type: Review

References (22)

1. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet. 2000;355:479-485.
2. Schrump DS AN, Henschke CL, et al. Non-small cell lung cancer. In: DeVita VT HS, Rosenberg SA, editors. Cancer: Principles and Practices of Oncology. Philadelphia: Lippincott Williams & Wilkins, 2005:753-810.
3. Rekhtman N, Brandt SM, Sigel CS, et al. Suitability of thoracic cytology for new therapeutic paradigms in nonsmall cell lung carcinoma: high accuracy of tumor subtyping and feasibility of Egfr and Kras molecular testing. J Thorac Oncol. 2011;6:451-458.
4. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Pathology and genetics of tumors of the lung, pleura, thymus and heart. In: Kleihues P, Sobin LH, editors. World health Organization Classification of Tumours. Lyon, France: IARC Press; 2004.
5. Motoi N, Szoke J, Riely GJ, et al. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis. Am J Surg Pathol. 2008;32:810-827.
6. Amin MB, Tamboli P, Merchant SH, et al. Micropapillary component in lung adenocarcinoma: a distinctive histologic feature with possible prognostic significance. Am J Surg Pathol. 2002;26:358-364.
7. Kamiya K, Hayashi Y, Douguchi J, et al. Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma. Mod Pathol. 2008;21: 992-1001.
8. Makimoto Y, Nabeshima K, Iwasaki H, et al. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (
9. Riquet M, Foucault C, Berna P, et al. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping. Ann Thorac Surg. 2006;81:1988-1995.
10. Barletta JA, Yeap BY, Chirieac LR. Prognostic significance of grading in lung adenocarcinoma. Cancer. 2010; 116:659-669.
11. Sica G, Yoshizawa A, Sima CS, et al. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors. Am J Surg Pathol. 2010;34:1155-1162.
12. Travis WD, Brambilla E, Noguchi M, et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6:244-285.
13. MacDonald LL, Yazdi HM. Fine-needle aspiration biopsy of bronchioloalveolar carcinoma. Cancer. 2001;93:29-34.
14. Ohori NP, Santa Maria EL. Cytopathologic diagnosis of bronchioloalveolar carcinoma: does it correlate with the 1999 world health organization definition? Am J Clin Pathol. 2004;122:44-50.
15. Vazquez MF, Koizumi JH, Henschke CI, Yankelevitz DF. Reliability of cytologic diagnosis of early lung cancer. Cancer. 2007;111:252-258.
16. Rudomina DE, Lin O, Moreira AL. Cytologic diagnosis of pulmonary adenocarcinoma with micropapillary pattern: does it correlate with the histologic findings? Diagn Cytopathol. 2009;37:333-339.
17. Dabbs DJ, Silverman JF. Prognostic factors from the fineneedle aspirate: breast carcinoma nuclear grade. Diagn Cytopathol. 1994;10:203-208.
18. Edge SB. American Joint Committee on Cancer: AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2009.
19. Dabbs DJ. Prognostic information from fine-needle aspiration biopsy of breast carcinoma. Am J Clin Pathol. 2000; 113:S76-83.
20. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6:655-663.
21. Petersen I, Kotb WF, Friedrich KH, et al. Core classification of lung cancer: correlating nuclear size and mitoses with ploidy and clinicopathological parameters. Lung Cancer. 2009;65:312-318.
22. Sneige N. Nuclear grading in fine needle aspirates of the breast. Cytopathol Annu. 1992;2:161-171.